Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma. [electronic resource]
Producer: 20170410Description: 1183-90 p. digitalISSN:- 1532-2157
- Adenocarcinoma -- pathology
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Chemoradiotherapy
- Esophageal Neoplasms -- pathology
- Esophagectomy -- methods
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Postoperative Complications -- epidemiology
- Radiotherapy, Conformal
- Retrospective Studies
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.